Informational intervention
OtherReceive information focusing on skin cancer
NCT Number: NCT03677739
This trial studies how well Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention works in improving skin examination in participants with melanoma and their families. Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention may help improve total cutaneous examinations, skin self-examinations, and sun protection among first degree relatives of young onset participants and the participants themselves.
This study is active but is not currently recruiting participants.
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
PRIMARY OBJECTIVES:
I. To examine the efficacy of the Young Melanoma Family Facebook intervention versus the Healthy Lifestyle Facebook intervention on total cutaneous exam (primary outcome), skin self-exam frequency and comprehensiveness, and sun protection practices (secondary outcomes) of first degree relatives (FDRs) of young melanoma survivors.
SECONDARY OBJECTIVES:
I. To examine the efficacy of the Young Melanoma Family Facebook intervention on patients? skin self-exam frequency and comprehensiveness and sun protection habits.
II. To examine the mechanisms of intervention efficacy.
OUTLINE:
PHASE I: Researchers refine content for the Facebook intervention condition and conduct usability testing.
PHASE II: Participants are randomized to 1 of 2 arms.
ARM I: Participants join a secret Young Melanoma Family Facebook Group and view post messages focusing on skin cancer for 12 weeks.
ARM II: Participants join a secret Healthy Lifestyle Facebook Group and view post messages focusing on healthy lifestyle for 12 weeks.
PHASE III: Dissemination planning.
After completion of study, participants are followed up at 6 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Receive information focusing on skin cancer
Ancillary studies
Time frame: At 6 months
Will be assessed as a binary response (yes/no) did participant have one
Time frame: Up to 5 years
Skin self-exam of first degree relatives will be analyzed as a binary (yes/no) Response did participant complete one Yes/No
Time frame: Up to 5 years
Skin self exam of first degree relatives count response will be calculated as frequency/month. Frequency per month reported as a number.
Time frame: Up to 5 years
: Skin self-exam of first degree relatives comprehensiveness calculated as total # body parts examined during the skin self-exam
Time frame: Up to 5 years
sun protection habits score of first degree relatives will be calculated as continuous variables using the Sun protection behaviors scale (Glanz, et. al., 2002) which measures 5 behaviors (regular outdoor use of: sunscreen, hat, shade, long-sleeved shirt, sunglasses).
Time frame: Up to 5 years
Skin self-exam of patients count response calculated as (frequency/month). Frequency per month reported as a number
Time frame: Up to 5 years
Skin self-exam of patients comprehensiveness calculated as total # body parts examined during the skin self-exam.
Time frame: Up to 5 years
sun protection habits score of patients will be calculated as continuous variables using the Sun protection behaviors scale (Glanz, et. al., 2002) which measures 5 behaviors (regular outdoor use of: sunscreen, hat, shade, long-sleeved shirt, sunglasses).
Time frame: 6 months
Mediator analyses examining normative influences on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Mediator analyses examining family and peer support and discussion on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Mediator analyses examining risk on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Mediator analyses examining benefits on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Mediator analyses examining barriers on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Mediator analyses examining self-efficacy on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Mediator analyses examining use of change strategies on the effects of intervention group on TCE, SSE and sun protection.
Time frame: 6 months
Moderator analysis Melanoma risk factors will explore whether the intervention group is more effective for subsets of FDRs.
Time frame: 6 months
Moderator analysis month of the year enrolled will explore whether the intervention group is more effective for subsets of FDRs.
Time frame: 6 months
Moderator analysis residential latitude will explore whether the intervention group is more effective for subsets of FDRs.
Time frame: 6 months
Moderator analysis sex will explore whether the intervention group is more effective for subsets of FDRs.
Time frame: 6 months
Moderator analysis patient disease stage will explore whether the intervention group is more effective for subsets of FDRs.
Time frame: 6 months
Moderator analysis relationship to patient will explore whether the intervention group is more effective for subsets of FDRs.
Time frame: 6 months
Facebook engagement including likes, comments- collected at the end of the group
Time frame: 6 months
Social network use measured by self-reported frequency of use of popular social media sites
Rutgers, The State University of New Jersey
Other
Facebook Intervention for Young Onset Melanoma Patients and Families
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03819296
Bronchial Neoplasms, Carcinoma, Bronchogenic
Houston, Texas, United States
View Trial DetailsNCT07621614
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
View Trial DetailsNCT07259304
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT04875728
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8
Houston, Texas, United States
View Trial Details